Workflow
Hyundai Palisade Named Best Midsize SUV in Good Housekeeping's 2026 Family Car Awards
Prnewswire· 2025-12-18 18:12
All-new Hyundai Palisade powers past the three-row competition with compelling gas and hybrid powertrain options FOUNTAIN VALLEY, Calif., Dec. 18, 2025 /PRNewswire/ -- The all-new Hyundai Palisade has been named Best Midsize SUV in Good Housekeeping's 2026 Family Car Awards. The winners were selected based on input from the Good Housekeeping Institute experts, Car and Driver editors, and real-world families.   Continue Reading The 2026 Hyundai Palisade is photographed in Bodega Bay, Calif., on ...
lululemon vs. Guess: Which Apparel Big-Wig has a Competitive Edge?
ZACKS· 2025-12-18 18:11
Key Takeaways LULU drives 7% y/y growthin 3Q25, led by 33% international gains and China up 46% in constant currency.Guess's focus on margins, inventory discipline and international reach aids profits despite macro pressures.LULU trades at 15.97X forward P/E vs. GES at 9.7X, highlighting valuation differences amid global expansion.In the global apparel landscape, lululemon athletica inc. (LULU) and Guess? Inc. (GES) occupy sharply different yet increasingly competitive positions. LULU commands a premium sha ...
Why Carnival (CCL) is Poised to Beat Earnings Estimates Again
ZACKS· 2025-12-18 18:11
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Carnival (CCL) , which belongs to the Zacks Leisure and Recreation Services industry.This cruise operator has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 27.08%.For the last reported quarter, Carnival came out with earnings of $1.4 ...
Nucor Corporation (NYSE: NUE) Faces Earnings Pressure but Remains Optimistic for 2026
Financial Modeling Prep· 2025-12-18 18:10
Core Viewpoint - Nucor Corporation is facing challenges in its fourth-quarter earnings guidance, which is below analyst expectations, but remains optimistic about recovery in 2026 due to improving order backlogs [2][4][6] Financial Performance - Nucor's projected earnings per share (EPS) for the fourth quarter is between $1.65 and $1.75, which is below the consensus estimate of $2.18 [2][6] - The company's current stock price is $160.69, reflecting a decrease of 0.97% or $1.57 [5] - Nucor's market capitalization is approximately $36.78 billion [5] Operational Segments - The anticipated decline in earnings is attributed to seasonal pressures and fewer shipping days, affecting all three operating segments: steel mills, steel products, and raw materials [3] - In the steel mills segment, earnings are expected to decrease due to lower volumes and margin compression, particularly in sheet products [3] - The steel products segment faces challenges with lower volumes and higher average costs per ton, although improved average pricing may provide some relief [3] Shareholder Actions - Nucor has continued its share repurchase program, buying back approximately 0.7 million shares in the fourth quarter at an average price of $145.23, bringing total repurchases for the year to about 5.4 million shares [4][6] Market Outlook - Despite current challenges, Nucor remains optimistic about a recovery in 2026, driven by improving order backlogs [4][6]
Australian Open, Sony Pictures Networks India extend broadcast partnership
The Economic Times· 2025-12-18 18:09
Under the renewed deal, SPNI retains exclusive television and SPNI has been broadcasting the Australian Open in India since 2015 and has played a key role in expanding the tournament’s reach in the region. The extension strengthens the Australian Open’s presence in one of its fastest-growing international markets and ensures comprehensive access for millions of The Australian Open traditionally opens the global tennis calendar and features many of the sport’s leading players, reinforcing its position as on ...
Athira Pharma recovers from Alzheimer's failure with breast cancer pivot and $90M investment
GeekWire· 2025-12-18 18:09
In a remarkable pivot, Athira Pharma has a deal to test a promising breast cancer drug and landed $90 million in upfront funding from investors. ...
Kulicke and Soffa Industries, Inc. (KLIC): A Bull Case Theory
Insider Monkey· 2025-12-18 18:08
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...
CLOZ: Floating-Rate Income-Hold Case
Seeking Alpha· 2025-12-18 18:08
The Eldridge BBB-B CLO ETF ( CLOZ ) is a way to receive attractive monthly income. However, we expect future dividends to be lower due to the downward trend in the SOFR rate and its relationship to the type of debtAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than ...
Saturn Oil & Gas Inc. (SOIL:CA) Discusses 2026 Capital Budget, Development Strategy and Flexible Asset Management Transcript
Seeking Alpha· 2025-12-18 18:07
PresentationI will now turn the meeting over to Mr. John Jeffrey, CEO of Saturn. Please go ahead, John.Good morning, ladies and gentlemen. Welcome to the Saturn Oil and Gas 2026 Guidance and Budget Conference Call. [Operator Instructions] And the conference is being recorded. [Operator Instructions]John JeffreyCEO, President & Non-Independent Director Thank you, and good morning, everyone. We appreciate you joining us to hear more about Saturn's disciplined 2026 budget and guidance released yesterday aftern ...
Humana Inc. (NYSE:HUM) Overview: Stock Performance and Market Outlook
Financial Modeling Prep· 2025-12-18 18:06
Core Viewpoint - Humana Inc. is a prominent health insurance provider in the U.S., recently rated "Underperform" by Morgan Stanley, which has lowered its price target for the company [1][6]. Financial Performance - Morgan Stanley adjusted Humana's price target from $277 to $262, while the stock was priced at $260.28, reflecting a slight increase of $2.12 or 0.82% [2][6]. - Humana's stock has fluctuated between $256.35 and $266.08 during the day, with a yearly high of $315.35 and a low of $206.87. The company's market capitalization is approximately $31.3 billion [4][6]. Contracts and Partnerships - The U.S. Defense Department awarded Humana a $7.3 billion contract for health care and administrative support services, indicating a strong relationship with the Pentagon and potential positive impacts on future financial performance [3][5][6]. Market Activity - Today's trading volume for Humana is 1,073,203 shares, indicating significant investor interest despite the "Underperform" rating from Morgan Stanley [5][6].